News & insights

Kilburn & Strode uphold Band 1 ranking in Chambers and Partners

News

Kilburn & Strode uphold Band 1 ranking in Chambers and Partners

We are delighted to announce our Band 1 ranking for Intellectual Property: Patent & Trade Mark Attorneys UK-wide. The report states that we are a ‘leading destination for filing, portfolio management and rights strategy.’

Innovation Capture 101

Thoughts

Innovation Capture 101

How knowing the basics of innovation capture can lead to competitive advantage and long-term business success.

Kilburn & Strode uphold Tier 1 ranking in Legal 500 for patents and trade marks

News

Kilburn & Strode uphold Tier 1 ranking in Legal 500 for patents and trade marks

The firm has been noted for all-round excellence and our partners have been individually acknowledged for their industry expertise.

Mastering the business of patents

Thoughts

Mastering the business of patents

How understanding the stable EPO approach to patent eligibility for business method and software inventions could improve your success rates in Europe, the US and beyond

Kilburn & Strode builds on success of San Francisco Liaison Office venture by expanding team in San Francisco

News

Kilburn & Strode builds on success of San Francisco Liaison Office venture by expanding team in San Francisco

Emily Collins and Tom Hamer bolster the firm’s offering in the United States by responding to market demand for European IP in California.

C 239/19 – CJEU rules UK SPC referral inadmissible – no guidance on when the patent holder for an SPC is not also the Marketing Authorisation holder

News

C 239/19 – CJEU rules UK SPC referral inadmissible – no guidance on when the patent holder for an SPC is not also the Marketing Authorisation holder

The CJEU has decided that there is no issue to be heard in this referral and has ruled it inadmissible. The matter relates to a dispute between Genentech and Eli Lilly, where Genentech has applied for an SPC based on an Eli Lilly marketing authorisation.

SPC News – Advocate General (AG) Opinion in CJEU referrals C-114/18 (Sandoz) and C-650/17 (Royalty Pharma)

News

SPC News – Advocate General (AG) Opinion in CJEU referrals C-114/18 (Sandoz) and C-650/17 (Royalty Pharma)

As expected, the AG published his opinion in the above CJEU referrals on the 11th September 2019. The issue at hand is the interpretation of Article 3(a) of the SPC Regulation (EC 469/2009) which states that an SPC shall be granted for a ‘product protected by a basic patent in force’.

No-deal Brexit: the basics

Brexit

No-deal Brexit: the basics

If there is a “no-deal” Brexit how quickly must we act? Patents will not change, unlike EU trade marks and EU registered designs.

Changing the game: Tomorrow’s tech in the video game space

Thoughts

Changing the game: Tomorrow’s tech in the video game space

It’s National Video Game Day! To celebrate, we’re exploring innovation in this exciting area by taking a look at patent trends in video game technologies at the European Patent Office (EPO).

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept